<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35316214</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1558-8238</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>132</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of clinical investigation</Title>
          <ISOAbbreviation>J Clin Invest</ISOAbbreviation>
        </Journal>
        <ArticleTitle>ZFP36L2 suppresses mTORc1 through a P53-dependent pathway to prevent peripartum cardiomyopathy in mice.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e154491</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI154491</ELocationID>
        <Abstract>
          <AbstractText>Pregnancy is associated with substantial physiological changes of the heart, and disruptions in these processes can lead to peripartum cardiomyopathy (PPCM). The molecular processes that cause physiological and pathological changes in the heart during pregnancy are not well characterized. Here, we show that mTORc1 was activated in pregnancy to facilitate cardiac enlargement that was reversed after delivery in mice. mTORc1 activation in pregnancy was negatively regulated by the mRNA-destabilizing protein ZFP36L2 through its degradation of Mdm2 mRNA and P53 stabilization, leading to increased SESN2 and REDD1 expression. This pathway impeded uncontrolled cardiomyocyte hypertrophy during pregnancy, and mice with cardiac-specific Zfp36l2 deletion developed rapid cardiac dysfunction after delivery, while prenatal treatment of these mice with rapamycin improved postpartum cardiac function. Collectively, these data provide what we believe to be a novel pathway for the regulation of mTORc1 through mRNA stabilization of a P53 ubiquitin ligase. This pathway was critical for normal cardiac growth during pregnancy, and its reduction led to PPCM-like adverse remodeling in mice.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kouzu</LastName>
            <ForeName>Hidemichi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tatekoshi</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Hsiang-Chun</ForeName>
            <Initials>HC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shapiro</LastName>
            <ForeName>Jason S</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McGee</LastName>
            <ForeName>Warren A</ForeName>
            <Initials>WA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Jesus</LastName>
            <ForeName>Adam</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ben-Sahra</LastName>
            <ForeName>Issam</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Northwestern University, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arany</LastName>
            <ForeName>Zoltan</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leor</LastName>
            <ForeName>Jonathan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Research Institute, Tel Aviv University and Sheba Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Chunlei</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blackshear</LastName>
            <ForeName>Perry J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Signal Transduction Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ardehali</LastName>
            <ForeName>Hossein</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Feinberg Cardiovascular and Renal Research Institute and.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>T32 DK007169</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Invest</MedlineTA>
        <NlmUniqueID>7802877</NlmUniqueID>
        <ISSNLinking>0021-9738</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051816">Tristetraprolin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000628667">Trp53 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C497553">Zfp36 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.11.1.-</RegistryNumber>
          <NameOfSubstance UI="D010544">Peroxidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.11.1.-</RegistryNumber>
          <NameOfSubstance UI="C529380">sestrin 2 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076222" MajorTopicYN="Y">Mechanistic Target of Rapamycin Complex 1</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009687" MajorTopicYN="Y">Nuclear Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058725" MajorTopicYN="N">Peripartum Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010544" MajorTopicYN="N">Peroxidases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="Y">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051816" MajorTopicYN="N">Tristetraprolin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016159" MajorTopicYN="Y">Tumor Suppressor Protein p53</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cardiology</Keyword>
        <Keyword MajorTopicYN="N">Cardiovascular disease</Keyword>
        <Keyword MajorTopicYN="N">Cell Biology</Keyword>
        <Keyword MajorTopicYN="N">Heart failure</Keyword>
        <Keyword MajorTopicYN="N">p53</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>17</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35316214</ArticleId>
        <ArticleId IdType="pmc">PMC9106345</ArticleId>
        <ArticleId IdType="doi">10.1172/JCI154491</ArticleId>
        <ArticleId IdType="pii">154491</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(12):1003–1008. doi: 10.1161/CIRCULATIONAHA.114.009029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.009029</ArticleId>
            <ArticleId IdType="pubmed">25223771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robson SC, et al.  Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94(11):1028–1039. doi: 10.1111/j.1471-0528.1987.tb02286.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-0528.1987.tb02286.x</ArticleId>
            <ArticleId IdType="pubmed">3322367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ardehali H, et al.  Peripartum cardiomyopathy. Minerva Cardioangiol. 2003;51(1):41–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12652259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindley KJ, et al.  Peripartum cardiomyopathy: progress in understanding the etiology, management, and prognosis. Heart Fail Clin. 2019;15(1):29–39. doi: 10.1016/j.hfc.2018.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.hfc.2018.08.004</ArticleId>
            <ArticleId IdType="pubmed">30449378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel PA, et al.  A contemporary review of peripartum cardiomyopathy. Clin Med (Lond) 2017;17(4):316–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6297639</ArticleId>
            <ArticleId IdType="pubmed">28765406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goland S, et al.  Angiogenic imbalance and residual myocardial injury in recovered peripartum cardiomyopathy patients. Circ Heart Fail. 2016;9(11):e003349.  doi: 10.1161/CIRCHEARTFAILURE.116.003349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.116.003349</ArticleId>
            <ArticleId IdType="pubmed">28029641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patten IS, et al.  Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333–338. doi: 10.1038/nature11040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11040</ArticleId>
            <ArticleId IdType="pmc">PMC3356917</ArticleId>
            <ArticleId IdType="pubmed">22596155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brooks SA, Blackshear PJ. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim Biophys Acta. 2013;1829(6–7):666–679.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3752887</ArticleId>
            <ArticleId IdType="pubmed">23428348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stumpo DJ, et al.  Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood. 2009;114(12):2401–2410. doi: 10.1182/blood-2009-04-214619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-04-214619</ArticleId>
            <ArticleId IdType="pmc">PMC2746470</ArticleId>
            <ArticleId IdType="pubmed">19633199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos SB. Characterization of DeltaN-Zfp36l2 mutant associated with arrest of early embryonic development and female infertility. J Biol Chem. 2012;287(16):13116–13127. doi: 10.1074/jbc.M111.330837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.330837</ArticleId>
            <ArticleId IdType="pmc">PMC3339969</ArticleId>
            <ArticleId IdType="pubmed">22367205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodson DJ, et al.  Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol. 2010;11(8):717–724. doi: 10.1038/ni.1901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.1901</ArticleId>
            <ArticleId IdType="pmc">PMC2953641</ArticleId>
            <ArticleId IdType="pubmed">20622884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galloway A, et al.  RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science. 2016;352(6284):453–459. doi: 10.1126/science.aad5978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aad5978</ArticleId>
            <ArticleId IdType="pubmed">27102483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;169(2):361–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28388417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meikle L, et al.  A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. Hum Mol Genet. 2005;14(3):429–435. doi: 10.1093/hmg/ddi039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddi039</ArticleId>
            <ArticleId IdType="pubmed">15601645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taneike M, et al.  mTOR hyperactivation by ablation of tuberous sclerosis complex 2 in the mouse heart induces cardiac dysfunction with the increased number of small mitochondria mediated through the down-regulation of autophagy. PLoS One. 2016;11(3):e0152628.  doi: 10.1371/journal.pone.0152628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0152628</ArticleId>
            <ArticleId IdType="pmc">PMC4811538</ArticleId>
            <ArticleId IdType="pubmed">27023784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng M, et al.  Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell. 2014;159(1):122–133. doi: 10.1016/j.cell.2014.08.038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.08.038</ArticleId>
            <ArticleId IdType="pmc">PMC4181352</ArticleId>
            <ArticleId IdType="pubmed">25259925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y, et al.  Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth. PLoS One. 2013;8(1):e54221.  doi: 10.1371/journal.pone.0054221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0054221</ArticleId>
            <ArticleId IdType="pmc">PMC3544830</ArticleId>
            <ArticleId IdType="pubmed">23342106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazelin L, et al.  mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis. J Mol Cell Cardiol. 2016;97:213–225. doi: 10.1016/j.yjmcc.2016.04.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2016.04.011</ArticleId>
            <ArticleId IdType="pubmed">27133769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang D, et al.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest. 2010;120(8):2805–2816. doi: 10.1172/JCI43008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI43008</ArticleId>
            <ArticleId IdType="pmc">PMC2912201</ArticleId>
            <ArticleId IdType="pubmed">20644257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrison DE, et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392–395. doi: 10.1038/nature08221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08221</ArticleId>
            <ArticleId IdType="pmc">PMC2786175</ArticleId>
            <ArticleId IdType="pubmed">19587680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flynn JM, et al.  Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013;12(5):851–862. doi: 10.1111/acel.12109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/acel.12109</ArticleId>
            <ArticleId IdType="pmc">PMC4098908</ArticleId>
            <ArticleId IdType="pubmed">23734717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McMullen JR, et al.  Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation. 2004;109(24):3050–3055. doi: 10.1161/01.CIR.0000130641.08705.45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.0000130641.08705.45</ArticleId>
            <ArticleId IdType="pubmed">15184287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bell SE, et al.  The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn. 2006;235(11):3144–3155. doi: 10.1002/dvdy.20949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvdy.20949</ArticleId>
            <ArticleId IdType="pubmed">17013884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stumpo DJ, et al.  Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol. 2004;24(14):6445–6455. doi: 10.1128/MCB.24.14.6445-6455.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.24.14.6445-6455.2004</ArticleId>
            <ArticleId IdType="pmc">PMC434251</ArticleId>
            <ArticleId IdType="pubmed">15226444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato T, et al.  mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function. Proc Natl Acad Sci U S A. 2018;115(27):E6291–E6300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6142244</ArticleId>
            <ArticleId IdType="pubmed">29915044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanduja S, et al.  The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdiscip Rev RNA. 2011;2(1):42–57. doi: 10.1002/wrna.28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/wrna.28</ArticleId>
            <ArticleId IdType="pmc">PMC3030256</ArticleId>
            <ArticleId IdType="pubmed">21278925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dumdie JN, et al.  Chromatin modification and global transcriptional silencing in the oocyte mediated by the mRNA decay activator ZFP36L2. Dev Cell. 2018;44(3):392–402. doi: 10.1016/j.devcel.2018.01.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2018.01.006</ArticleId>
            <ArticleId IdType="pmc">PMC5805474</ArticleId>
            <ArticleId IdType="pubmed">29408237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, et al.  ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors. Nature. 2013;499(7456):92–96. doi: 10.1038/nature12215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature12215</ArticleId>
            <ArticleId IdType="pmc">PMC3702661</ArticleId>
            <ArticleId IdType="pubmed">23748442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dibble CC, Manning BD. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol. 2013;15(6):555–564. doi: 10.1038/ncb2763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb2763</ArticleId>
            <ArticleId IdType="pmc">PMC3743096</ArticleId>
            <ArticleId IdType="pubmed">23728461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon S, et al.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell. 2014;156(4):771–785. doi: 10.1016/j.cell.2013.11.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.11.049</ArticleId>
            <ArticleId IdType="pmc">PMC4030681</ArticleId>
            <ArticleId IdType="pubmed">24529379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bar-Peled L, et al.  A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science. 2013;340(6136):1100–1106. doi: 10.1126/science.1232044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1232044</ArticleId>
            <ArticleId IdType="pmc">PMC3728654</ArticleId>
            <ArticleId IdType="pubmed">23723238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfson RL, et al.  Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. 2016;351(6268):43–48. doi: 10.1126/science.aab2674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aab2674</ArticleId>
            <ArticleId IdType="pmc">PMC4698017</ArticleId>
            <ArticleId IdType="pubmed">26449471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canal M, et al.  RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders. Front Cell Neurosci. 2014;8:313. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183088</ArticleId>
            <ArticleId IdType="pubmed">25324725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parmigiani A, Budanov AV. Sensing the environment through sestrins: implications for cellular metabolism. Int Rev Cell Mol Biol. 2016;327:1–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27692174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413–431. doi: 10.1016/j.cell.2009.04.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.04.037</ArticleId>
            <ArticleId IdType="pubmed">19410540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 2008;134(3):451–460. doi: 10.1016/j.cell.2008.06.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.06.028</ArticleId>
            <ArticleId IdType="pmc">PMC2758522</ArticleId>
            <ArticleId IdType="pubmed">18692468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Budanov AV, et al.  Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene. 2002;21(39):6017–6031. doi: 10.1038/sj.onc.1205877.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1205877</ArticleId>
            <ArticleId IdType="pubmed">12203114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellisen LW, et al.  REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell. 2002;10(5):995–1005. doi: 10.1016/S1097-2765(02)00706-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00706-2</ArticleId>
            <ArticleId IdType="pubmed">12453409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol. 2003;13(1):49–58. doi: 10.1016/S1044-579X(02)00099-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1044-579X(02)00099-8</ArticleId>
            <ArticleId IdType="pubmed">12507556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung E, et al.  Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation. J Appl Physiol (1985) 2012;112(9):1564–1575. doi: 10.1152/japplphysiol.00027.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/japplphysiol.00027.2012</ArticleId>
            <ArticleId IdType="pmc">PMC3362236</ArticleId>
            <ArticleId IdType="pubmed">22345431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hennig M, et al.  Prenatal mechanistic target of rapamycin complex 1 (m TORC1) inhibition by rapamycin treatment of pregnant mice causes intrauterine growth restriction and alters postnatal cardiac growth, morphology, and function. J Am Heart Assoc. 2017;6(8):e005506.  doi: 10.1161/JAHA.117.005506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.117.005506</ArticleId>
            <ArticleId IdType="pmc">PMC5586418</ArticleId>
            <ArticleId IdType="pubmed">28778941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng Z, et al.  The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A. 2005;102(23):8204–8209. doi: 10.1073/pnas.0502857102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0502857102</ArticleId>
            <ArticleId IdType="pmc">PMC1142118</ArticleId>
            <ArticleId IdType="pubmed">15928081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben Sahra I, et al.  Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res. 2011;71(13):4366–4372. doi: 10.1158/0008-5472.CAN-10-1769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-10-1769</ArticleId>
            <ArticleId IdType="pubmed">21540236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones RG, et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18(3):283–293. doi: 10.1016/j.molcel.2005.03.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2005.03.027</ArticleId>
            <ArticleId IdType="pubmed">15866171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine AJ, et al.  Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 2006;20(3):267–275. doi: 10.1101/gad.1363206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1363206</ArticleId>
            <ArticleId IdType="pubmed">16452501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sofer A, et al.  Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol. 2005;25(14):5834–5845. doi: 10.1128/MCB.25.14.5834-5845.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.25.14.5834-5845.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1168803</ArticleId>
            <ArticleId IdType="pubmed">15988001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben-Sahra I, et al.  Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ. 2013;20(4):611–619. doi: 10.1038/cdd.2012.157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2012.157</ArticleId>
            <ArticleId IdType="pmc">PMC3595485</ArticleId>
            <ArticleId IdType="pubmed">23238567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brugarolas J, et al.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004;18(23):2893–2904. doi: 10.1101/gad.1256804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1256804</ArticleId>
            <ArticleId IdType="pmc">PMC534650</ArticleId>
            <ArticleId IdType="pubmed">15545625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mak TW, et al.  p53 regulates the cardiac transcriptome. Proc Natl Acad Sci U S A. 2017;114(9):2331–2336. doi: 10.1073/pnas.1621436114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1621436114</ArticleId>
            <ArticleId IdType="pmc">PMC5338492</ArticleId>
            <ArticleId IdType="pubmed">28193895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sablina AA, et al.  The antioxidant function of the p53 tumor suppressor. Nat Med. 2005;11(12):1306–1313. doi: 10.1038/nm1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1320</ArticleId>
            <ArticleId IdType="pmc">PMC2637821</ArticleId>
            <ArticleId IdType="pubmed">16286925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfeffer TJ, et al.  Increased cancer prevalence in peripartum cardiomyopathy. JACC CardioOncol. 2019;1(2):196–205. doi: 10.1016/j.jaccao.2019.09.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaccao.2019.09.008</ArticleId>
            <ArticleId IdType="pmc">PMC8352111</ArticleId>
            <ArticleId IdType="pubmed">34396183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, et al.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600. doi: 10.1016/j.cell.2006.12.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2006.12.036</ArticleId>
            <ArticleId IdType="pubmed">17289576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ardehali H, et al.  Cardioprotective role of the mitochondrial ATP-binding cassette protein 1. Circ Res. 2005;97(8):740–742. doi: 10.1161/01.RES.0000186277.12336.11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.0000186277.12336.11</ArticleId>
            <ArticleId IdType="pmc">PMC2756018</ArticleId>
            <ArticleId IdType="pubmed">16166555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ackers-Johnson M, et al.  A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ Res. 2016;119(8):909–920. doi: 10.1161/CIRCRESAHA.116.309202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309202</ArticleId>
            <ArticleId IdType="pmc">PMC5965670</ArticleId>
            <ArticleId IdType="pubmed">27502479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sawicki KT, et al.  Increased heme levels in the heart lead to exacerbated ischemic injury. J Am Heart Assoc. 2015;4(8):e002272.  doi: 10.1161/JAHA.115.002272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.115.002272</ArticleId>
            <ArticleId IdType="pmc">PMC4599478</ArticleId>
            <ArticleId IdType="pubmed">26231844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu R, et al.  Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med. 2012;4(7):633–646. doi: 10.1002/emmm.201200240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/emmm.201200240</ArticleId>
            <ArticleId IdType="pmc">PMC3407950</ArticleId>
            <ArticleId IdType="pubmed">22517678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bayeva M, et al.  mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metab. 2012;16(5):645–657. doi: 10.1016/j.cmet.2012.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.10.001</ArticleId>
            <ArticleId IdType="pmc">PMC3594686</ArticleId>
            <ArticleId IdType="pubmed">23102618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bray NL, et al.  Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34(5):525–527. doi: 10.1038/nbt.3519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.3519</ArticleId>
            <ArticleId IdType="pubmed">27043002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pimentel H, et al.  Differential analysis of RNA-seq incorporating quantification uncertainty. Nat Methods. 2017;14(7):687–690. doi: 10.1038/nmeth.4324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmeth.4324</ArticleId>
            <ArticleId IdType="pubmed">28581496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation> McGee WA, et al. Compositional data analysis is necessary for simulating and analyzing RNA-Seq data [preprint].   Posted on bioRxiv May 2, 2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/564955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vesentini N, et al.  Selection of reference genes in different myocardial regions of an in vivo ischemia/reperfusion rat model for normalization of antioxidant gene expression. BMC Res Notes. 2012;5(1):124.  doi: 10.1186/1756-0500-5-124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-0500-5-124</ArticleId>
            <ArticleId IdType="pmc">PMC3392735</ArticleId>
            <ArticleId IdType="pubmed">22377061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brattelid T, et al.  Reference gene alternatives to Gapdh in rodent and human heart failure gene expression studies. BMC Mol Biol. 2010;11(1):22.  doi: 10.1186/1471-2199-11-22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2199-11-22</ArticleId>
            <ArticleId IdType="pmc">PMC2907514</ArticleId>
            <ArticleId IdType="pubmed">20331858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi L, et al.  Gene-level differential analysis at transcript-level resolution. Genome Biol. 2018;19(1):53.  doi: 10.1186/s13059-018-1419-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13059-018-1419-z</ArticleId>
            <ArticleId IdType="pmc">PMC5896116</ArticleId>
            <ArticleId IdType="pubmed">29650040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gruber AR, et al.  AREsite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res. 2011;39(database issue):D66–D69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3013810</ArticleId>
            <ArticleId IdType="pubmed">21071424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichikawa Y, et al.  Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617–630. doi: 10.1172/JCI72931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72931</ArticleId>
            <ArticleId IdType="pmc">PMC3904631</ArticleId>
            <ArticleId IdType="pubmed">24382354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brumback LC, et al.  Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging. 2010;26(4):459–468. doi: 10.1007/s10554-010-9584-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10554-010-9584-5</ArticleId>
            <ArticleId IdType="pmc">PMC3037862</ArticleId>
            <ArticleId IdType="pubmed">20107905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De la Grandmaison GL, et al.  Organ weight in 684 adult autopsies: new tables for a Caucasoid population. Forensic Sci Int. 2001;119(2):149–154. doi: 10.1016/S0379-0738(00)00401-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0379-0738(00)00401-1</ArticleId>
            <ArticleId IdType="pubmed">11376980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar NT, et al.  Postmortem heart weight: relation to body size and effects of cardiovascular disease and cancer. Cardiovasc Pathol. 2014;23(1):5–11. doi: 10.1016/j.carpath.2013.09.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.carpath.2013.09.001</ArticleId>
            <ArticleId IdType="pubmed">24121021</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
